The stock market is a battlefield right now.

Investors are shell-shocked from last week’s massive selloff, and fear is in the air. The tech sector is bleeding, and even the mighty Nvidia is down nearly 20% from its recent high! Meanwhile, the financial media is blaring headlines about the coming recession, warning us to batten down the hatches and brace for impact!

But here at Today’s Top Stocks, we don’t buy into the hype. We know that fear and uncertainty create the best opportunities for investors who have the guts to go against the grain. And right now, there’s one sector that’s quietly preparing for a massive boom: financials.

Why Financials?

Because the Federal Reserve is about to unleash the floodgates of easy money with a series of interest rate cuts. The market is pricing in at least a 0.25% cut at the Fed’s September 18th policy meeting, with expectations for more rate cuts in the months ahead.

And that’s music to the ears of financial companies. Lower interest rates will boost lending activity, increase profitability, and bolster the value of their assets. In fact, we’re already seeing the financial sector surge ahead of the pack, with the XLF ETF trading near its recent highs.

My friend Chris Johnson of Money Morning has been all over this trade for weeks.

He recently released a watch list of three financial companies he believes are poised to profit from the impending rate cuts. These stocks offer a unique combination of growth and income, perfect for investors who are looking to secure their financial future.

So without further ado, here are Chris Johnson’s top three dividend plays in the financial sector:

Medtronic (MDT)

Medtronic is a global medical technology giant with a dominant position in cardiac, vascular, neurological, and diabetes-related devices.

Chris Johnson believes Medtronic is an excellent buy opportunity right now, citing the company’s strong earnings results and the bullish breakout in the stock’s price. He highlights the recent Golden Cross, a bullish signal generated when the stock’s 50-day moving average crosses above its 200-day moving average, as a clear sign of positive momentum.

Johnson states: “Shares of MDT just formed a bullish Golden Cross pattern as the stock is heading towards a $250 price, but that’s the beginning… Watch for a $275 price target on shares of Teleflex over the next 3-6 months.” [Read Chris Johnson’s full analysis here.]

I agree with Chris’s analysis – MDT is a solid play with a healthy dividend yield. You're investing in a company with a dominant market position and a bright outlook, all while collecting a steady stream of passive income.

Clorox (CLX)

Clorox is a household name known for their cleaning and disinfecting products, a product category with consistently high demand, making it a true consumer staple.

Chris Johnson argues that Clorox’s stock price is benefiting from being a staple as investors begin to worry about the economy slowing. He expects the stock price to rally higher as investors look for companies with strong dividends who are likely to continue performing well regardless of what happens to economic growth.

Johnson writes: “Shares are trading in a bullish trend according to the rising 50-day moving average. That trendline just crossed above the stock’s 200-day moving average to form a bullish Golden Cross… Watch for momentum to drive the stock to a target price of $200 as investors continue to look for dividend-yielding growth stocks in 2025.” [Read Chris Johnson’s full analysis here.]

This pick aligns perfectly with my thesis that the “easy money” trade is over, and investors are preparing for a more volatile market. A company like Clorox should be able to maintain its high level of performance regardless of what happens to the economy.

Teleflex (TFX)

Teleflex is a global medical technology company that develops catheters, airway management tools, and other surgical instruments for healthcare professionals.

Chris Johnson believes Teleflex is a long-term bullish play as the stock consolidates its recent breakout to new highs. He says the stock is consolidating near $250 and expects a breakout higher from this trading range to reach his $275 target price.

“Shares of TFX just formed a bullish Golden Cross pattern as the stock is heading towards a $250 price, but that’s the beginning… Watch for a $275 price target on shares of Teleflex over the next 3-6 months,” writes Johnson.[Read Chris Johnson’s full analysis here.]

I agree with Chris’s bullish take – TFX is a great example of a company that blends growth and income. You're buying into a company at the forefront of healthcare innovation, with a solid dividend to boot.

Don’t miss out on this opportunity!

Download my free report, “3 Dividend Stocks to BUY Before the Boom,” and discover why these companies are primed for massive gains. These stocks are a cornerstone of my portfolio, and I'm confident they'll help you secure your financial future.

Tomorrow, I'll reveal a play that's even hotter – a POWERHOUSE chipmaker that's set to explode 40% higher, while everyone panics about NVDA. Don't miss out – it's going to be a wild ride!